BECTON DICKINSON & CO (BDX) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-10 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: BECTON DICKINSON & CO (BDX) CIK: 0000010795 --- Reporting Owner --- Name: Garrison Michael David CIK: 0001944816 Role: Officer (EVP & Pres Med.Essntl&BioPharm) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-06-10 | Code: S (Open market sale) Shares: -1,100 | Price: $151.48 Total Value: $166,628.00 Shares Owned After: 14,272 | Ownership: D (Direct) Footnotes: [F1] Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. --- Footnotes (Complete Index) --- F1: Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. --- Signature --- /s/ Donna Kalazdy, by power of attorney from Michael David Garrison (2026-06-11)